MCKESSON CORP cotiza a 955.76 USD y tiene una capitalización bursátil de $111.4B. En los últimos 12 meses ha facturado $411.0B con un margen de flujo de caja libre del 1.4%. Cotiza a 17.4 veces su flujo de caja libre (P/FCF) y a un PER de 24.3. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: North American Pharmaceutical, Oncology & Multispecialty, Prescription Technology Solutions, and Medical-Surgical Solutions. The company distributes branded, generic, specialty, biosimilar and …
| Periodo | 2026-11 | 2026-08 | 2026-05 | 2026-02 |
|---|---|---|---|---|
| Real | — | $9.93 | $11.69 | $9.34 |
| Estimado | $10.77 | $9.54 | $11.57 | $9.27 |
| Sorpresa | — | +4.1% | +1.0% | +0.8% |
| Métrica | MCK | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 3.6% | 57.0% | -53.4% |
| Operating Margin | 1.5% | -38.6% | +40.2% |
| Net Margin | 1.2% | -33.6% | +34.7% |
| FCF Margin | 1.4% | -13.9% | +15.3% |
| ROE | — | -40.4% | — |
| ROA | 5.8% | -32.0% | +37.8% |
| Current Ratio | 0.85 | 2.84 | -1.99 |
| Debt / Equity | -3.00 | 0.28 | -3.28 |